SUMMARY In a prospective randomised study, 289 children admitted consecutively to hospital with their first febrile seizure were allocated, by date of admission, to short term diazepam prophylaxis (n=152) or to no prophylaxis (n=137) and followed for 18 months. In untreated children, five major risk factors for recurrent febrile convulsions were identified: age 15 months or less at the time of the first febrile seizure, epilepsy in first degree relatives, febrile convulsions in first degree relatives, a first complex febrile seizure, and day nursery care. The 18 month recurrence rate was 80 to 100% if three to five risk factors were present, 50% if two factors were identified, 25% where one factor was found, and 12% if there were no predictors. During prophylaxis the recurrence rate was uniformly low (mean 12%) in all risk groups. In high (three or more factors) and intermediate (two factors) risk children prophylaxis provided effective seizure control and reduced the recurrence rate from 80%, or more, to 12% and 50% to 12%, respectively. In children with one risk factor 50% of all recurrences were prevented (25% to 12%). Prophylaxis was ineffective in very low risk children (12% to 12%).
In recent studies various risk factors for recurrent febrile convulsions have been identified. "There is, however, little available evidence on the interaction of these risk factors and on their influence on the recurrence risk with or without prophylaxis.
In a prospective randomised study we investigated the efficacy of short term diazepam prophylaxis in 289 children referred consecutively to hospital with their first febrile seizure. The results from this study have already been reported. 6 We have now identified major risk factors for recurrent febrile seizures in these 289 children, stratified the children according to the risk of a recurrence, and analysed the efficacy of prophylaxis in high, intermediate, and low risk children given either short term diazepam prophylaxis at times of fever for 18 months or no prophylaxis. Pharmacokinetic and clinical data on short term diazepam prophylaxis have also been reported elsewhere. [7] [8] Material and methods Among 326 children referred consecutively to hospital during the period 1 June 1978 to 1 June 1980 with their first simple or complex febrile seizure, 289 were included in the study as The control group (n=137) ( Table 1 ) comprised 80 boys and 57 girls of whom 131 (96%) had had convulsions of short duration and 6 (4%) of long duration. Altogether 112 (82%) had had a simple and 25 (18%) a complex first seizure. No significant differences between the two groups were found in respect of sex, age, type and duration of convulsions, and family history of epilepsy and febrile convulsions.
The number of children with recurrences versus the total number of children in the stratified prophylaxis and control groups are given in Table 2 . (9) 'P values and SD are derived from log rank test and Cox's analysis. (Fig. 1) .
During prophylaxis the recurrence rate was uniformly low (mean 12%) in all risk groups (Fig. 2) .
The reduction in the recurrence risk associated with prophylaxis ( Figs. 1 and 2) was strongly influenced by the number of predictors. In high and intermediate risk children, prophylaxis afforded effective seizure control and reduced the recurrence rate from 80% or more to 12% and from 50% to 12%, respectively. In low risk children, comprising 40%, 50% of all the recurrences were prevented (25% to 12%), whereas very low risk children (28% of the study group) did not respond to prophylaxis (12% to 12%).
The predictive value of the best positive or negative answer to the question of whether an individual child would have another febrile seizure within 18 months is given in 
Discussion
The study indicates that at least five factors influence the seizure recurrence rate. Furthermore, the number of predictors identified in each child seems to be useful in identifying those who are likely to have further febrile seizures. It seems that each risk factor, whether genetic or environmental, contributes to the recurrence risk in a cumulative way; the more items identified the higher the recurrence rate.
In an effort to estimate the recurrence risk more accurately, a prognostic index based on a six point scale was established. For practical purposes weak and strong predictors were assigned equal predictive power. In terms of risk groups, the risk assessment seemed to be reliable and a fairly good correlation between predicted and actual outcome was obtained. Thus, populations at low, intermediate, and high risk of future febrile seizures could readily be identified by means of the proposed scoring system. There is no reason, however, to suggest that the occurrence of recurrent febrile convulsions could be accurately predicted in an individual child. The prediction seemed especially inaccurate in children belonging to the intermediate group.
Moreover, genetic10-2 and probably socioeconomic factors may influence the type, number, interplay, and power of the predictors, and the items used to assess the recurrence risk in our study may not be appropriate for all geographical locations. Biased reporting of the family history and the type of convulsion may further reduce the predictive value.
Most studies, including ours, agree that early age at the time of the first febrile seizure is the most powerful predictor for subsequent febrile convulsions.1-4 10 In the perinatal collaborative study only two risk factors were identified-early age at the time of initial seizure and a history of epilepsy in the near family, whereas a complex first febrile seizure and sex were not related to the recurrence rate. 4 were observed from diazepam prophylaxis. In the prophylaxis group, the parents described mild, transient side effects in 65%: sedation (36%), euphoria (15%), ataxia (8%), aggressiveness (2%).
One child (0-6%) had a dental fracture probably related to ataxia. The parents managed the treatment surprisingly well, and compliance problems were minimal, provided that careful instruction concerning administration procedures and side effects were given. Only 4% of the children in the prophylaxis group had a recurrent febrile seizure despite alleged adequate prophylaxis. In only 4% of children allocated to prophylaxis a recurrence of febrile convulsions occurred because administration of diazepam was deliberately omitted by the parents.
The present study shows that the main effect of diazepam prophylaxis at times of fever is to provide effective seizure control in high and intermediate risk 
